Explain to me why a royalty stream is necessary? Any oncologist could pair DCVax once approved with an approved adjuvant. A partnership not even with an adjuvant position could get part of the revenue stream with a partnership on trial funding.
I can see royalties from Flaskworks if the system is set up at the site of surgery.
I do not see the argument for multiple partnerships. Feel free to explain why.
Market Data 
Markets 
AI
